Seres Therapeutics
MCRB
#10361
Rank
HK$0.36 B
Marketcap
HK$36.68
Share price
2.62%
Change (1 day)
-75.59%
Change (1 year)

Market capitalization of Seres Therapeutics (MCRB)

Market cap: HK$0.36 Billion

As of August 2026 Seres Therapeutics has a market cap of HK$0.36 Billion. This makes Seres Therapeutics the world's 10361th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Seres Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.36 B-64.27%
2025HK$1.03 B-7.61%
2024HK$1.11 B-21.03%
2023HK$1.41 B-74.07%
2022HK$5.45 B-8.66%
2021HK$5.96 B-65.64%
2020HK$17.37 B821.68%
2019HK$1.88 B30.07%
2018HK$1.44 B-54.87%
2017HK$3.21 B3.64%
2016HK$3.09 B-70.85%
2015HK$10.62 B

End of Day market cap according to different sources

On Aug 23rd, 2026 the market cap of Seres Therapeutics was reported to be:

HK$0.35 Billion
by Nasdaq info icon info icon
HK$0.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
HK$16.57 B 4,398.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
HK$15.28 B 4,048.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.66 B 23,151.50%๐Ÿ‡บ๐Ÿ‡ธ USA